Relapsing polychondritis in children: A review

References

• Jaksch-Wartenhorst R. Polychondropathia. Wien Arch Inn Med. 1923;6:93–100.
   Google Scholar
• Cohen PR, Rapini RP. Polychondritis. Int J Dermatol. 1986;25:280–5.
   PubMed Web of Science ®Google Scholar
• Hazra N, Dregan A, Charlton J, Gulliford MC, D'Cruz DP. Incidence and mortality of relapsing polychondritis in the UK: a population-based cohort study. Rheumatology (Oxford). 2015;54:2181–7.
   PubMed Web of Science ®Google Scholar
• Kong KO, Vasoo S, Tay NS, Chng HH. Relapsing polychondriti—an oriental case series. Singapore Med J. 2003;44:197–200.
   PubMedGoogle Scholar
• Trentham DE. Relapsing polychondritis. Ann Intern Med. 1998;129:114–22.
   PubMed Web of Science ®Google Scholar
• Belot A, Duquesne A, Job-Deslandre C, Costedoat-Chalumeau N, Boudjemaa S, Wechsler B, et al. Pediatric-onset relapsing polychondritis: case series and systematic review. J Pediatr. 2010;156:484–9.
   PubMed Web of Science ®Google Scholar
• Yanagi T, Matsumura T, Kamekura R, Sasaki N, Hashino S. Relapsing polychondritis and malignant lymphoma: is polychondritis paraneoplastic? Arch Dermatol. 2007;143:89–90.
   PubMedGoogle Scholar
• Michet CJ. Vasculitis and relapsing polychondritis. Rheum Dis Clin North Am 1990;16:441–4.
   PubMed Web of Science ®Google Scholar
• Varonos S, Kostaki M, Tsapra H, Pantelidak A, Karpathios TH. Polychondritis associated with Schönlein-Henoch purpura: report of a case. Clin Exp Rheumatol. 1994;12:443–5.
   PubMed Web of Science ®Google Scholar
• Botey A, Navasa M, del Olmo A, Montoliu J, Ferrer O, Cardesa A, et al. Relapsing polychondritis with segmental necrotizing glomerulonephritis. Am J Nephrol. 1984;4:375–8.
   PubMed Web of Science ®Google Scholar
• Karaca NE, Aksu G, Yildiz B, Gulez N, Turk B, Dereli T, Kutukculer N. Relapsing polychondritis in a child with common variable immunodeficiency. Int J Dermatol. 2009;48:525–8.
   PubMed Web of Science ®Google Scholar
• Blau EB. Relapsing polychondritis and retroperitoneal fibrosis in an 8-year-old-boy. Arch Pediatr Adolesc Med. 1976;130:1149–52.
   Google Scholar
• McAdam LP, OʼHanlan MA, Bluestone R, Pearson CM. Relapsing polychondritis: prospective study of 23 patients and a review of the literature. Medicine (Baltimore). 1976;55:193–215.
   PubMed Web of Science ®Google Scholar
• Damiani JM, Levine HL. Relapsing polychondritis-report of ten cases. Laryngoscope. 1979;89:929–46.
   PubMed Web of Science ®Google Scholar
• Michet CJ Jr, McKenna CH, Luthra HS, O'Fallon WM. Relapsing polychondritis: survival and predictive role of early disease manifestations. Ann Intern Med. 1986;104:74–8.
   PubMed Web of Science ®Google Scholar
• Fonseca AR, de Oliveira SK, Rodrigues MC, Aymoré IL, Domingues RC, Sztajnbok FR. Relapsing polychondritis in childhood: three case reports, comparison with adulthood disease and literature review. Rheumatol Int. 2013;33:1873–88.
   PubMed Web of Science ®Google Scholar
• Valenzuela R, Cooperrider PA, Gogate P, Deodhar SD, Bergfeld WF. Relapsing polychondritis. Immunomicroscopic findings in cartilage of ear biopsy specimens. Hum Pathol. 1980;11:19–22.
   PubMed Web of Science ®Google Scholar
• Alsalameh S, Mollenhauer J, Scheuplein F, Stöss H, Kalden JR, Burkhardt H, Burmester GR. Preferential cellular and humoral immune reactivities to native and denatured collagen types IX and XI in a patient with fatal relapsing polychondritis. J Rheumatol. 1993;20:1419–24.
   PubMed Web of Science ®Google Scholar
• Arnaud L, Devilliers H, Peng SL, Mathian A, Costedoat-Chalumeau N, Buckner J, et al. The Relapsing Polychondritis Disease Activity Index: development of a disease activity score for relapsing polychondritis. Autoimmun Rev. 2012;12:204–9.
   PubMed Web of Science ®Google Scholar
• Rednic S, Damian L, Talarico R, Scirè CA, Tobias A, Costedoat-Chalumeau N, et al. Relapsing polychondritis: state of the art on clinical practice guidelines. RMD Open. 2018;4:e000788.
   PubMed Web of Science ®Google Scholar
• Dolan DL, Lemmon GB, Jr, Teitelbaum SL. Relapsing polychondritis. Analytical literature review and studies on pathogenesis. Am J Med. 1966;41:285–99.
   PubMed Web of Science ®Google Scholar
• Hughes RA, Berry CL, Seifert M, Lessof MH. Relapsing polychondritis. Three cases with a clinico-pathological study and literature review. Q J Med. 1972;41:363–80.
   PubMedGoogle Scholar
• Herman JH, Dennis MV. Immunopathologic studies in relapsing polychondritis. J Clin Invest. 1973;52:549–58.
   PubMed Web of Science ®Google Scholar
• Rajapakse DA, Bywaters EG. Cell-mediated immunity to cartilage proteoglycan in relapsing polychondritis. Clin Exp Immunol. 1974;16:497–502.
   PubMed Web of Science ®Google Scholar
• Gange RW. Relapsing polychondritis. Report of two cases with an immunopathological review. Clin Exp Dermatol. 1976;1:261–8.
   PubMed Web of Science ®Google Scholar
• Foidart JM, Abe S, Martin GR, Zizic TM, Barnett EV, Lawley TJ, Katz SI. Antibodies to type II collagen in relapsing polychondritis. N Engl J Med. 1978;299:1203–7.
   PubMed Web of Science ®Google Scholar
• Wooley PH, Luthra HS, O'Duffy JD, Bunch TW, Moore SB, Stuart JM. Anti-type II collagen antibodies in rheumatoid arthritis. The influence of HLA phenotype. Tissue Antigens. 2008;23:263–9.
   Google Scholar
• Terato K, Shimozuru Y, Katayama K, Takemitsu Y, Yamashita I, Miyatsu M, et al. Specificity of antibodies to type II collagen in rheumatoid arthritis. Arthritis Rheum. 1990;33:1493–500.
   PubMed Web of Science ®Google Scholar
• Burkhardt H, Koller T, Engström A, Nandakumar KS, Turnay J, Kraetsch HG, et al. Epitope-specific recognition of type II collagen by rheumatoid arthritis antibodies is shared with recognition by antibodies that are arthritogenic in collagen-induced arthritis in the mouse. Arthritis Rheum. 2002;46:2339–48.
   PubMed Web of Science ®Google Scholar
• Lang B, Rothenfusser A, Lanchbury JS, Rauh G, Breedveld FC, Urlacher A, et al. Susceptibility to relapsing polychondritis is associated with HLA-DR4. Arthritis Rheum. 1993;36:660–4.
   PubMed Web of Science ®Google Scholar
• Zeuner M, Straub RH, Rauh G, Albert ED, Scholmerich J, Lang B. Relapsing polychondritis: clinical and immunogenetic analysis of 62 patients. J Rheumatol. 1997;24:96–101.
   PubMed Web of Science ®Google Scholar
• Arnaud L, Mathian A, Haroche J, Gorochov G, Amoura Z. Pathogenesis of relapsing polychondritis: a 2013 update. Autoimmun Rev. 2014;13:90–5.
   PubMed Web of Science ®Google Scholar
• Lin DF, Yang WQ, Zhang PP, Lv Q, Jin O, Gu JR. Clinical and prognostic characteristics of 158 cases of relapsing polychondritis in China and review of the literature. Rheumatol Int. 2016; 36:1003–9.
   PubMed Web of Science ®Google Scholar
• Alqanatish JT, Alfarhan BA, Qubaiban SM. Limited auricular relapsing polychondritis in a child treated successfully with infliximab. BMJ Case Rep. 2019;12:e227043.
   PubMedGoogle Scholar
• Nakayama K, Yamamoto S, Uetake K, Yamada M, Tozawa Y, Ueki M, et al. Relapsing polychondritis with increased bone marrow signal on magnetic resonance imaging in a 13-year-old girl. J Clin Rheumatol. 2018;24:52–4.
   PubMed Web of Science ®Google Scholar
• Taşlı H, Birkent H, Gerek M. Three cases of relapsing polycondritis with isolated laryngotracheal stenosis. Turk Arch Otorhinolaryngol. 2017; 55:77–82.
   PubMed Web of Science ®Google Scholar
• Wu MF, Li YS, Hung CY, Chao WC, Fu ZY, Kao KC, et al. Relapsing polychondritis with initial presentations of recurrent negative-pressure pulmonary edema and acute respiratory failure. Respir Care. 2015;60:e101–4.
   PubMed Web of Science ®Google Scholar
• Navarrete VM, Lebrón CV, de Miera FJ, Candau CP, Sarabia FN. Sustained remission of pediatric relapsing polychondritis with adalimumab. J Clin Rheumatol. 2014;20:45–6.
   PubMed Web of Science ®Google Scholar
• Buscatti IM, Giacomin MF, Silva MF, Campos LM, Sallum AM, Silva CA. Laryngotracheal stenosis requiring emergency tracheostomy as the first manifestation of childhood-relapsing polychondritis. Acta Reumatol Port. 2013;38:208–11.
   PubMed Web of Science ®Google Scholar
• Rohena-Quinquilla IR, Mullens F, Chung EM. MR findings in the arthropathy of relapsing polychondritis. Pediatr Radiol. 2013;43:1221–6.
   PubMed Web of Science ®Google Scholar
• Oliver AM, Simpson EM, Jerath RS. A rare cause of ear pain in a young boy. J Pediatr. 2012;160:350.
   PubMed Web of Science ®Google Scholar
• Abdwani R, Kolethekkat AA, Al Abri R. Abri R. Refractory relapsing polychondritis in a child treated with antiCD20 monoclonal antibody (rituximab): First case report. Int J Pediatr Otorhinolaryngol. 2012;76:1061–4.
   PubMed Web of Science ®Google Scholar
• Li CH, Lin YS, Liang SJ. A saddle nose with acute respiratory failure. Intern Emerg Med. 2012;7:51–2.
   Web of Science ®Google Scholar
• Mellado F, Talesnik E, Castiglione E. Azathioprine as monotherapy for scleritis in relapsing polychondritis. Ocul Immunol Inflamm. 2012;20:235–6.
   PubMed Web of Science ®Google Scholar
• Buonuomo PS, Bracaglia C, Campana A, El Hachem M, Diociaiuti A, Insalaco A, et al. Relapsing polychondritis: new therapeutic strategies with biological agents. Rheumatol Int. 2010;30:691–3.
   PubMed Web of Science ®Google Scholar
• Zulian F, Sari M, de Filippis C. Otolaryngological manifestations of rheumatic diseases in children. Int J Pediatr Otorhinolaryngol. 2009;73 :S56–S60.
   PubMed Web of Science ®Google Scholar
• de Oliveira SK, Fonseca AR, Domingues RC, Aymoré IL. A unique articular manifestation in a child with relapsing polychondritis. J Rheumatol. 2009;36:659–60.
   PubMed Web of Science ®Google Scholar
• Ernst A, Rafeq S, Boiselle P, Sung A, Reddy C, Michaud G, et.al. Relapsing polychondritis and airway involvement. Chest. 2009;135:1024–30.
   PubMed Web of Science ®Google Scholar
• Ghosn S, Malek J, Shbaklo Z, Matta M, Uthman I. Takayasu disease presenting as malignant pyoderma gangrenosum in a child with relapsing polychondritis. J Am Acad Dermatol. 2008;59:S84–S7.
   PubMed Web of Science ®Google Scholar
• Bell D, Wright D, Witt PD. Durability of nasal reconstruction in an adolescent with relapsing polychondritis treated with infliximab. Plast Reconstr Surg. 2007;120:1087–8.
   PubMed Web of Science ®Google Scholar
• Terrier B, Aouba A, Bienvenu B, Bloch-Queyrat C, Delair E, Mallet J, et al. Complete remission in refractory relapsing polychondritis with intravenous immunoglobulins. Clin Exp Rheumatol. 2008;26:136–8.
   PubMed Web of Science ®Google Scholar
• Yamaoka K, Saito K, Hanami K, Nakayamada S, Nawata M, Iwata S, et al. A case of life-threatening refractory polychondritis successfully treated with combined intensive immunosuppressive therapy with methotrexate. Mod Rheumatol. 2007;17:144–7.
   PubMedGoogle Scholar
• Kim CM, Kim BS, Cho KJ, Hong SJ. Laryngotracheal Involvement of Relapsing Polychondritis in a Korean Girl. Pediatr Pulmonol. 2003;35:314–7.
   PubMed Web of Science ®Google Scholar
• Rozin AP, Schapira D, Bergman R. Alopecia areata and relapsing polychondritis or mosaic autoimmunity? The first experience of co-trimoxazole treatment. Ann Rheum Dis. 2003;62:778–80.
   PubMed Web of Science ®Google Scholar
• Kraus VB, Stabler T, Le ET, Saltarelli M, Allen NB. Urinary type II collagen neoepitope as an outcome measure for relapsing polychondritis. Arthritis Rheum. 2003;48:2942–8.
   PubMedGoogle Scholar
• Navarro MJ, Higgins GC, Lohr KM, Myers LK. Amelioration of relapsing polychondritis in a child treated with oral collagen. Am J Med Sci. 2002;324:101–3.
   PubMed Web of Science ®Google Scholar
• Soto-Romero I, Fustes-Morales AJ, De Leon-Bojorge B, Contreras-Ruiz J, Ruiz-Maldonado R. Relapsing polychondritis: a pediatric case. Pediatr Dermatol. 2002;19:60–3.
   PubMed Web of Science ®Google Scholar
• Fadl FA, Hassan KM, Oyetunji NM, Al-Nour SA. Ear, nose and throat manifestations of relapsing polychondritis in a child. Saudi Med J. 2001;22:718–20.
   PubMed Web of Science ®Google Scholar
• Knipp S, Bier H, Horneff G, Specker C, Schuster A, Schroten H, et al. Relapsing polychondritis in childhood – case report and short review. Rheumatol Int. 2000;19:231–4.
   PubMed Web of Science ®Google Scholar
• Okuyama C, Ushijima Y, Sugihara H, Okitsu S, Ito H, Maeda T. Increased subglottic gallium uptake in relapsing polychondritis. J Nucl Med. 1998;39:1977–9.
   PubMed Web of Science ®Google Scholar
• Sacco O, Fregonese B, Oddone M, Verna A, Tassara E, Mereu C, et al. Severe endobronchial obstruction in a girl with relapsing polychondritis: treatment with Nd YAG laser and endobronchial silicon stent. Eur Respir J. 1997;10:494–6.
   PubMed Web of Science ®Google Scholar
• Balsa A, Expinosa A, Cuesta M, MacLeod TI, Gijón-Baños J, Maddison PJ. Joint symptoms in relapsing polychondritis. Clin Exp Rheumatol 1995;13:425–30.
   PubMed Web of Science ®Google Scholar
• Clark LJ, Wakeel RA, Ormerod AD. Relapsing polychondritis two cases with tracheal stenosis and inner ear involvement. J Laryngol Otol. 1992;106:841–4.
   PubMed Web of Science ®Google Scholar
• Oddone M, Tomà P, Taccone A, Hanau G, Delogu A, Gemme G. Relapsing polychondritis in childhood: a rare observation studied by CT and MRI. Pediatr Radiol. 1992;22:537–8.
   PubMed Web of Science ®Google Scholar
• Lipnick RN, Fink CW. Acute airway obstruction in relapsing polychondritis: treatment with pulse methylprednisolone. J Rheumatol. 1991;18:98–9.
   PubMed Web of Science ®Google Scholar
• Trepel RJ, Lipnick RN, D'Angelo L. Relapsing polychondritis in an adolescent. J Adolesc Health Care. 1989;10:557–60.
   PubMedGoogle Scholar
• Rothstein J, Adams GL, Galliani CA, Elliott GR. Relapsing polychondritis in a 30-month-old child. Otolaryngol Head Neck Surg. 1985;93:680–3.
   PubMed Web of Science ®Google Scholar
• Matoba A, Plager S, Barber J, McCulley JP. Keratitis in relapsing polychondritis. Ann Ophthalmol. 1984;16:367–70.
   PubMedGoogle Scholar
• Mestres CA, Igual A, Botey A, Revert L, Murtra M. Relapsing polychondritis with glomerulonephritis and severe aortic insufficiency surgically treated with success. Thorac Cardiovasc Surg. 1983;31:307–9.
   PubMed Web of Science ®Google Scholar
• Bachor E, Blevins NH, Karmody C, Kühnel T. Otologic manifestations of relapsing polychondritis. Review of literature and report of nine cases. Auris Nasus Larynx. 2006;33:135–41.
   PubMed Web of Science ®Google Scholar
• Giordano M, Valentini G, Sodano A. Relapsing polychondritis with aortic arch aneurysm and aortic arch syndrome. Rheumatol Int. 1984;4:191–3.
   PubMed Web of Science ®Google Scholar
• Firestein GS, Gruber HE, Weisman MH, Zvaifler NJ, Barber J, O'Duffy JD. Mouth and genital ulcers with inflamed cartilage: MAGIC syndrome. Five patients with features of relapsing polychondritis and Behcet’s disease. Am J Med. 1985;79:65–72.
   PubMed Web of Science ®Google Scholar
• Miller EB, Friedman JA, Lahav Y, Landau Z. Relapsing polychondritis and familial Mediterranean fever an association. Clin Rheumatol. 2011;30:711–3.
   PubMed Web of Science ®Google Scholar
• Salihoglu A, Seyahi E, Celik S, Yurdakul S. Relapsing polychondritis in a patient with familial Mediterranean fever and amyloidosis. Clin Exp Rheumatol. 2008;26:S125.
   PubMed Web of Science ®Google Scholar
• Davidi E, Paz A, Duchman H, Luntz M, Potasman I. Perichondritis of the auricle: analysis of 114 cases. Isr Med Assoc J. 2011;13:21–4.
   PubMed Web of Science ®Google Scholar
• Borgia F, Giuffrida R, Guarneri F, Cannavò SP. Relapsing polychondritis: an updated review. Biomedicines. 2018;6:84.
   Web of Science ®Google Scholar
• Papo T, Piette JC, Le Thi Huong D. u, Godeau P, Meyer O, Kahn MF, Bourgeois P. Antineutrophil cytoplasmic antibodies in polychondritis. Ann Rheum Dis. 1993;52:384–5.
   PubMed Web of Science ®Google Scholar
• Ebringer R, Rook G, Swana GT, Bottazzo GF, Doniach D. Autoantibodies to cartilage and type IIcollagen in relapsing polychondritis and other rheumatic diseases. Ann Rheum Dis. 1981;40:473–9.
   PubMed Web of Science ®Google Scholar
• Yang CL, Brinckmann J, Rui HF, Vehring KH, Lehmann H, Kekow J, et al. Autoantibodies to cartilage collagens inrelapsing polychondritis. Arch Dermatol Res. 1993;285:245–9.
   PubMed Web of Science ®Google Scholar
• Kempta Lekpa F, Piette JC, Bastuji-Garin S, Kraus VB, Stabler TV, Poole AR, et al. Serum cartilage oligomeric matrix protein (COMP) level is a marker of disease activity in relapsing polychondritis. Clin Exp Rheumatol. 2010;28:553–5.
   PubMed Web of Science ®Google Scholar
• Sato T, Yamano Y, Tomaru U, Shimizu Y, Ando H, Okazaki T, et al. Serum level of soluble triggering receptor expressed on myeloid cells-1 as a biomarker of disease activity in relapsing polychondritis. Mod Rheumatol. 2014;24:129–36.
   PubMed Web of Science ®Google Scholar
• Stabler T, Piette JC, Chevalier X, Marini-Portugal A, Kraus VB. Serum cytokine profiles in relapsing polychondritis suggest monocyte/macrophage activation. Arthritis Rheum. 2004; 50:3663–7.
   PubMed Web of Science ®Google Scholar
• Behar JV, Choi YW, Hartman TA, Allen NB, McAdams HP. Relapsing polychondritis affecting the lower respiratory tract. AJR Am J Roentgenol. 2002;178:173–7.
   PubMed Web of Science ®Google Scholar
• Lin ZQ, Xu JR, Chen JJ, Hua XL, Zhang KB, Guan YJ. Pulmonary CT findings in relapsing polychondritis. Acta Radiol. 2010;51:522–6.
   PubMed Web of Science ®Google Scholar
• Fornadley JA, Seibert DJ, Ostrov BE, Warren WS. The role of MRI when relapsing polychondritis is suspected but not proven. Int J Pediatr Otorhinolaryngol. 1995;31:101–7.
   PubMed Web of Science ®Google Scholar
• Heman-Ackah YD, Remley KB, Goding GS Jr. A new role for magnetic resonance imaging in the diagnosis of laryngeal relapsing polychondritis. Head Neck. 1999;21:484–9.
   PubMed Web of Science ®Google Scholar
• Dupont A, Bossuyt A, Somers G. Relapsing polychondritis: Gallium-67 uptake in recurrent lung lesions. J Nucl Med Allied Sci. 1983;27:57–8.
   PubMedGoogle Scholar
• Chang MC, Tsai SC, Lin WY. Value of gallium-67 scanning in monitoring therapeutic effectiveness in a patient with relapsing polychondritis. Kaohsiung J Med Sci. 2008;24:328–33.
   PubMed Web of Science ®Google Scholar
• Kao CH, Wang SJ, Yeh S. Radionuclide imaging of relapsing polychondritis. Clin Nucl Med. 1992;17:397–8.
   PubMed Web of Science ®Google Scholar
• Shi XH, Zhang FC, Chen LB, Ouyang M. The value of 99mTc methylene diphosphonate bone scintigraphy in diagnosing relapsing polychondritis. Chin Med J (Engl). 2006;119:1129–32.
   PubMed Web of Science ®Google Scholar
• Murgu S, Kurimoto N, Colt H. Endobronchial ultrasound morphology of expiratory central airway collapse. Respirology. 2008;13:315–9.
   PubMed Web of Science ®Google Scholar
• Nishiyama Y, Yamamoto Y, Dobashi H, Kameda T, Satoh K, Ohkawa M. [18F] fluorodeoxyglucose positron emission tomography imaging in a case of relapsing polychondritis. J Comput Assist Tomogr. 2007;31:381–3.
   PubMed Web of Science ®Google Scholar
• Yamashita H, Takahashi H, Kubota K, Ueda Y, Ozaki T, Yorifuji H, et al. Utility of fluorodeoxyglucose positron emission tomography/computed tomography for early diagnosis and evaluation of disease activity of relapsing polychondritis: A case series and literature review. Rheumatology (Oxford). 2014;53:1482–90.
   PubMed Web of Science ®Google Scholar
• Deng H, Chen P, Wang L, Li X, Yi J. Relapsing polychondritis on PET/CT. Clin Nucl Med. 2012;37:712–5.
   PubMed Web of Science ®Google Scholar
• Sarodia BD, Dasgupta A, Mehta AC. Management of airway manifestations of relapsing polychondritis: case reports and review of literature. Chest. 1999;116:1669–75.
   PubMed Web of Science ®Google Scholar
• Kamada T, Ito I, Kanemitsu Y, Sato S, Matsumoto H, Niimi A, et al. Three-dimensional imaging forced oscillation technique to assess position-dependent airway obstruction in relapsing polychondritis: a case report. Respir Investig. 2017;55:69–73.
   PubMed Web of Science ®Google Scholar
• Gergely P, Poor G. Relapsing polychondritis. Best Pract Res Clin Rheumatol. 2004;18:723–38.
   PubMed Web of Science ®Google Scholar
• Yang H, Peng L, Jian M, Qin L. Clinical analysis of 15 patients with relapsing auricular polychondritis. Eur Arch Otorhinolaryngol. 2014;271:473–6.
   PubMed Web of Science ®Google Scholar
• Belot A, Collardeau-Frachon S, Bellil D, Descours G, Gillet Y. It sounds like a relapsing polychondritis. Lancet Infect Dis. 2013;13:638.
   PubMed Web of Science ®Google Scholar
• Puéchal X, Terrier B, Mouthon L, Costedoat-Chalumeau N, Guillevin L, Le Jeunne C. Relapsing polychondritis. Joint Bone Spine. 2014;81:118–24.
   PubMed Web of Science ®Google Scholar
• Letko E, Zafirakis P, Baltatzis S, Voudouri A, Livir-Rallatos C, Foster CS. Relapsing polychondritis: A clinical review. Semin Arthritis Rheum. 2002;31:384–95.
   PubMed Web of Science ®Google Scholar
• Cuestas D, Peñaranda E, Mora S, Cortes C, Galvis I, Patiño M, et al. Relapsing polychondritis, an underestimated dermatological urgency: case report and literature review. Int J Dermatol. 2017;56:1379–86.
   PubMed Web of Science ®Google Scholar
• Mathian A, Miyara M, Cohen-Aubart F, Haroche J, Hie M, Pha M, et al. Relapsing polychondritis: a 2016 update on clinical features, diagnostic tools, treatment and biological drug use. Best Pract Res Clin Rheumatol. 2016;30:316–33.
   PubMed Web of Science ®Google Scholar
• Martin J, Roenigk HH, Lynch W, Tingwald FR. Relapsing polychondritis treated with dapsone. Arch Dermatol. 1976;112:1272–4.
   PubMed Web of Science ®Google Scholar
• Smylie A, Malhotra N, Brassard A. Relapsing polychondritis: a review and guide for the dermatologist. Am J Clin Dermatol. 2017;18:77–86.
   PubMed Web of Science ®Google Scholar
• De Oliveira SK, de Almeida RG, Fonseca AR, Rodrigues MC, Sztajnbok F., Diniz C. Indications and adverse events with the use of anti-TNF alpha agents in pediatric rheumatology: experience of a single center. Acta Reumatol Port. 2007; 32:139–50.
   PubMed Web of Science ®Google Scholar
• Leroux G, Costedoat-Chalumeau N, Brihaye B, Cohen-Bittan J, Amoura Z, Haroche J, et al. Treatment of relapsing polychondritis with rituximab: a retrospective study of nine patients. Arthritis Rheum. 2009;61:577–82.
   PubMed Web of Science ®Google Scholar
• Moulis G, Sailler L, Pugnet G, Astudillo L, Arlet P. Biologics in relapsing polychondritis: a case series. Clin Exp Rheumatol. 2013;31:937–9.
   PubMed Web of Science ®Google Scholar
• Peng SL, Rodriguez D. Abatacept in relapsing polychondritis. Ann Rheum Dis. 2013;72:1427–9.
   PubMed Web of Science ®Google Scholar
• Liu L, Liu S, Guan W, Zhang L. Efficacy of tocilizumab for psychiatric symptoms associated with relapsing polychondritis: the first case report and review of the literature. Rheumatol Int. 2016;36:1185–9.
   PubMed Web of Science ®Google Scholar
• Loricera J, Blanco R, Castañeda S, Humbría A, Ortego-Centeno N, Narváez J, et al. Tocilizumab in refractory aortitis: study on 16 patients and literature review. Clin Exp Rheumatol. 2014;32:S79–S89.
   PubMed Web of Science ®Google Scholar
• Kresina TF, Yoo JU, Goldberg VM. Evidence that a humoral immune response to autologous cartilage proteoglycan can participate in the induction of cartilage pathology. Arthritis Rheum. 1988;31:248–57.
   PubMedGoogle Scholar
• Dion J, Costedoat-Chalumeau N, Sène D, Cohen-Bittan J, Leroux G, Dion C, et al. Relapsing polychondritis can be characterized by three different clinical phenotypes: analysis of a recent series of 142 patients. Arthritis Rheumatol. 2016;68:2992–3001.
   PubMed Web of Science ®Google Scholar